Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Haploidentical Bone Marrow Transplantation in Sickle Cell Patients (BMTCTN1507)

ClinicalTrials.gov ID: NCT03263559

Public ClinicalTrials.gov record NCT03263559. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 8:26 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Reduced Intensity Conditioning for Haploidentical Bone Marrow Transplantation in Patients With Symptomatic Sickle Cell Disease. (BMTCTN1507)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a Phase II, single arm, multi-center trial, designed to estimate the efficacy and toxicity of haploidentical bone marrow transplantation (BMT) in patients with sickle cell disease (SCD). Based on their age and entry criteria patients are stratified into two groups: (1) children with severe SCD; and (2) adults with severe SCD.

Study identification

NCT ID
NCT03263559
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
95 participants

Conditions and interventions

Eligibility (public fields only)

Age range
5 Years to 45 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 3, 2017 (Actual)
Primary completion
Jan 29, 2025 (Actual)
Completion
Jan 29, 2025 (Actual)
Last update posted
Jul 8, 2026

2017 – 2025

United States locations

U.S. sites
32
U.S. states
19
U.S. cities
27
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35294 —
UCSF Benioff Children's Hospital Oakland Oakland California 94609 —
University of Colorado - Denver/Children's Hospital of Colorado Aurora Colorado 80045 —
Children's National Medical Center Washington D.C. District of Columbia 20010 —
University of Florida College of Medicine Gainesville Florida 32610 —
Nicklaus Children's Hospital/University of Miami Children's Hospital Miami Florida 33155 —
H. Lee Moffitt Cancer Center Tampa Florida 33612 —
Northside Hospital Atlanta Georgia 30342 —
Riley Children's Hospital at IU Health Indianapolis Indiana 46020 —
Indiana University Medical Center Indianapolis Indiana 46202 —
Johns Hopkins University Baltimore Maryland 21287 —
Children's Hospital of Michigan Detroit Michigan 48201 —
Helen Devos Children's at Spectrum Health Grand Rapids Michigan 49503 —
Cardinal Glennon Children's Hospital St Louis Missouri 63104 —
Washington University, St. Louis St Louis Missouri 63110 —
Hackensack University Medical Center Hackensack New Jersey 07601 —
Roswell Park Cancer Center Buffalo New York 14203 —
Northwell Health/Monter Cancer Center Lake Success New York 11042 —
Levine Children's Hospital Charlotte North Carolina 28203 —
Duke University Medical Center Durham North Carolina 27705 —
University Hospitals of Cleveland/Case Western Cleveland Ohio 44106 —
Cleveland Clinic Foundation Cleveland Ohio 44195 —
Nationwide Children's Hospital Columbus Ohio 43205-2696 —
University of Pittsburgh Pittsburgh Pennsylvania 15260 —
Methodist Healthcare/West Cancer Center Memphis Tennessee 38104 —
St. Jude Children's Research Hospital Memphis Tennessee 38105 —
Vanderbilt University Medical Center Nashville Tennessee 37232 —
Texas Children's Hospital (Baylor) Houston Texas 77030 —
University of Texas/MD Anderson Cancer Center Houston Texas 77030 —
Texas Transplant Institute San Antonio Texas 78229 —
Fred Hutchinson Cancer Research Center Seattle Washington 98109 —
The Medical College of Wisconsin Wauwatosa Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03263559, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 8, 2026 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03263559 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →